Clinical Development Co-op

At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-β) family of proteins. With a focus on developing differentiated product candidates that are designed to alter TGF-β signaling, we aim to target the pathways critical for the growth, repair and maintenance of blood cells and a number of tissues, including bone, skeletal muscle, adipose and heart tissue.

We believe our product candidates have the potential to unlock the full therapeutic benefits of modulating the TGF-β superfamily and provide disease-modifying benefit to patients.

This person will assist with clinical trial documentation, literature reviews, data analysis, and study startup activities. This role is ideal for a student looking to gain experience in translating TGF- science into clinical therapies within a fast-paced, collaborative environment.

• Assist with the review of study start-up processes, data variability reduction, and drafting study protocols for consistency.
• Perform, synthesize, and present literature reviews on competitive landscapes and therapeutic approaches.
• Support the review and analysis of clinical data from ongoing or closing studies.
• Work with clinical operations, regulatory affairs, and research teams to support trial design.

• Strong interest in neurodegenerative diseases and TGF- signaling pathway science.
• Ability to conduct literature reviews, analyze clinical data, and interpret findings.

• Strong Microsoft Excel, PowerPoint, and Word skills for preparing documents.
• Excellent organizational, communication, and data analysis skills.
• Ability to work independently and as part of a team in a startup environment.

• Currently pursuing a Bachelor’s or Master’s in neuroscience, biology, pharmacology, or a related field.

Potential base pay range: $28—$32 USD.

Keros is an inclusive company. We believe that diversity drives innovation. We continue to build an inclusive culture that encourages, supports, and celebrates the diverse voices of our employees. As such, Keros takes a holistic approach in mentoring, coaching, and developing all of our Keros team members.

Keros Therapeutics is an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected veteran status, or any other characteristic protected by applicable federal, state, or local law.

Keros Therapeutics does not accept unsolicited resumes from any source other than the candidate directly. Any unsolicited submission by an agency to Keros is prohibited. Any resume submitted by an agency without a signed contract or expressed consent by a member of the Keros Therapeutics Human Resources Department, will be considered property of Keros Therapeutics, and no fee shall be owed with respect thereto.